Pamela L Kunz
Affiliation: Stanford University
- Carcinoid and neuroendocrine tumors: building on successPamela L Kunz
Stanford Cancer Center, Stanford, CA
J Clin Oncol 33:1855-63. 2015..This comprehensive review article summarizes recent advances in the field of neuroendocrine tumors and places them into context for best management practices. ..
- A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old maleStephen M Wanta
Georgetown University School of Medicine, Washington, DC
Rare Tumors 3:e45. 2011..We also performed a review of the literature and found three similar cases, however gene mutation analysis was not performed....
- Consensus guidelines for the management and treatment of neuroendocrine tumorsPamela L Kunz
Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305 5826, USA
Pancreas 42:557-77. 2013..Here, we present a set of consensus tables intended to complement these guidelines and serve as a quick, accessible reference for the practicing physician...
- Long-term survivors of gastric cancer: a California population-based studyPamela L Kunz
Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Dr, Stanford, CA 94025 5826, USA
J Clin Oncol 30:3507-15. 2012..In the United States, gastric cancer is rapidly fatal with a 25% 5-year survival. Of the few patients who survive, little is known about their demographic, clinical, and tumor characteristics...
- Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumorsMotaz Qadan
Department of Surgery, Stanford University Hospital and Clinics, Stanford, CA
J Am Coll Surg 218:188-95. 2014..Currently, the American Joint Committee on Cancer (AJCC) recommends use of the pancreatic adenocarcinoma staging system for PNETs. We sought to explore the prognostic usefulness of the pancreatic adenocarcinoma staging system for PNETs...
- Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?Manali I Patel
Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
Ann Surg Oncol 20:1631-8. 2013..We sought to validate the new system on a U.S. population database...
- Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasisGeorge A Poultsides
Department of Surgery, Stanford University School of Medicine, Stanford, CA, USA
Ann Surg Oncol 19:2295-303. 2012..Specifically, the prevalence and prognostic significance of radiographic calcifications in these tumors remains unclear...
- HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessmentPamela L Kunz
Department of Medicine Oncology, Stanford University, Stanford, CA 94305, USA
Appl Immunohistochem Mol Morphol 20:13-24. 2012....
- Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicityErqi L Pollom
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
Int J Radiat Oncol Biol Phys 90:918-25. 2014..We report updated outcomes of single- versus multifraction stereotactic body radiation therapy (SBRT) for unresectable pancreatic adenocarcinoma...
- Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressivenessDavid J Worhunsky
Department of Surgery, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
HPB (Oxford) 16:304-11. 2014..However, a subset of these tumours can be hypoenhancing. The prognostic significance of the CT appearance of these tumors remains unclear...
- Postradiotherapy CA19-9 kinetics correlate with outcomes in patients with pancreatic adenocarcinomaDavid B Shultz
From the Department of Radiation Oncology, and Division of Oncology, Department of Medicine, Stanford University and Stanford Cancer Institute, Stanford, CA
Pancreas 43:777-83. 2014..We sought to determine if carbohydrate antigen 19-9 (CA19-9 ) nadir (nCA19-9), time to nadir (TTN), and doubling time (DT) after radiotherapy (RT) correlate with outcomes in pancreatic ductal adenocarcinoma...
- Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosisStephanie T Chang
Department of Radiation Oncology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA
J Transl Med 7:105. 2009..Proximity ligation assay (PLA) is a highly sensitive technique for multiplex detection of biomarkers in plasma with little or no interfering background signal...
- Everolimus causing severe hypertriglyceridemia and acute pancreatitisSomasundaram Subramaniam
Stanford Cancer Institute, Stanford, California, USA
J Natl Compr Canc Netw 11:5-9. 2013..Because there are increasing indications for the use of everolimus, prescribing oncologists must be cognizant of the common and serious side effects...
- Capecitabine-induced chest pain relieved by diltiazemAndrew P Ambrosy
Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
Am J Cardiol 110:1623-6. 2012..In conclusion, guidelines for the evaluation of and therapy for capecitabine-induced chest pain are proposed...
- Advances in the treatment of gastroenteropancreatic neuroendocrine tumorsPamela L Kunz
Stanford University Medical Center, CA, USA
Clin Exp Gastroenterol 3:79-86. 2010..The rarity of these tumors, their resistance to standard chemotherapy, and the excellent performance status of most of these patients, make a strong argument for consideration of novel therapeutic trials...